• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ECYT:US

7.3599 USD 0.3799 5.44%

As of 20:10:00 ET on 08/29/2014.

Company Profile for Endocyte Inc (ECYT)

Endocyte Inc. is a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. The Company uses a proprietary technology to create small molecule drug conjugates, or SMDCs, and companion imaging diagnostics that actively target receptors that are over-expressed on diseased cells, relative to healthy cells.

Contact Information

Endocyte Inc

3000 Kent Avenue
Suite A 1-100
West Lafayette, IN 47906
United States
Phone: 1-765-463-7175
Fax: 1-765-463-9271

Key Executives for Endocyte Inc (ECYT)

P Ron EllisPresident/CEO/Co-FounderMichael A ShermanCFO/COO
Philip S LowChief Science OfficerBinh NguyenVP:Medical Affairs
Christopher P LeamonVP:ResearchMichael A BrinkleyVP:Quality
Scot L Harper "Scot"VP:Clinical OperationsChandra D LovejoyVP:Regulatory Affairs
Allen R RitterVP:ManufacturingBeth A TaylorController

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil